Joseph Rosenbluh
A/Prof. Rosenbluh is an expert in Cancer functional genomics and has led various screening efforts aimed at identifying genes, variants, pathways and drug targets associated with various cancer phenotypes. He has published seminal papers in highly influential journals describing the use of large scale genetic screens for identification of gene targets in cancer (Cell 2012, Cell 2012, Cell 2014, Nature Biotechnology 2016). He developed approaches for genetic interaction mapping (Cell Systems, 2016) the use of CRISPRi for genetic screens (Nature Communications, 2017). His lab has made major discoveries of genes associated with breast cancer risk (Genome Biology, 2023), transcript isoforms required for gastric cancer proliferation (Genome Biology, 2021) and annotation of circRNA function (Nature Cell Biology, 2024). In addition to his research lab he is the scientific director of the Monash Functional Genomics Platform.
Abstracts this author is presenting: